Presenter:Candy Stockton-Joreteg, M.D., FASAM
Opioid use disorder (OUD) in the US continues to rise, including among women of childbearing age. Pregnant women with opioid use disorder face many barriers to care, including stigma, limited access to treatment, and fear of legal consequences. This self-paced online course will cover the science and best practices in treating pregnant women with OUD and their infants, as well as a panel focused on case review and discussion.
Additional Topics related to MAT Providers: Best practices in admitting and treating pregnant and postpartum women with OUD. Talking with patients about the various medications to treat OUD. Best practices for treating OUD with the added complications of a benzodiazepine or alcohol use disorder during pregnancy Best practices for inducting medication for OUD in pregnant women. Best practices in referring pregnant patients to a higher level of care. Best practices for changing OUD medications and changing dosage during pregnancy. Addressing and reducing liability concerns with this population.
Additional Topics related to OB Providers: Partnering with substance use providers, coordination of care with SUD provider. Determining the most appropriate level of care to refer pregnant substance using patients to. Talking with patients about the various medications to treat OUD. .Best practices for treating OUD with the added complications of a benzodiazepine or alcohol use disorder during pregnancy. Best practices for inducting medication for OUD. Best practices for changing OUD medications and changing dosage during pregnancy. Addressing and reducing liability concerns with this population.
Continuing Education Units: 3 CEUs
This training is approved for CEUs by the following professional organizations:
Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Presentation materials are not for reproduction or distribution without specific written authorization. The opinions, findings, conclusions, and recommendations expressed in our courses are those of the author(s) and do not necessarily represent the official views of CASAT.
|End Date||12-31-2022 PDT|
|Registration Start Date||07-28-2021 PDT|
|Event Time Zone||PDT|
|Cut Off Date||12-31-2022 PDT|